| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $545.4M | +16.5% |
| Cost of Revenue | $143.3M | +7.5% |
| Gross Profit | $402.0M | +20.1% |
| R&D Expense | $153.1M | +10.0% |
| SG&A Expense | $114.5M | -4.6% |
| Operating Income | -$108.0M | +25.5% |
| Pre-tax Income | -$108.2M | +28.0% |
| Income Tax | $3.2M | +363.7% |
| Net Income | -$111.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $149.4M | +0.8% |
| Short-term Investments | $9.7M | -79.8% |
| Accounts Receivable | $171.6M | +3.4% |
| Current Assets | $414.4M | -1.9% |
| Total Assets | $627.5M | +5.6% |
| Current Liabilities | $371.2M | +37.3% |
| Long-term Debt | $206.6M | +74.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110.4M | -3.7% |
| Capital Expenditures | $9.6M | +6.0% |
| Investing Cash Flow | $28.6M | +178.5% |
| Financing Cash Flow | $79.2M | -44.6% |
| Free Cash Flow | -$120.1M | -3.8% |
| +26.2% |
| EPS (Basic) | -$1.52 | +26.9% |
| EPS (Diluted) | -$1.52 | +26.9% |
| Total Liabilities |
| $575.2M |
| +28.2% |
| Stockholders' Equity | $52.3M | -64.1% |